ACS Journal Cancer shared a post on X:
“Introducing Direct to CANCER, our expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for scope or priority reasons.”
Read further.
Source: ACS Journal Cancer/X